Long-Term Intensive Insulin Therapy for Japanese Patients with Type 2 Diabetes Mellitus-Reference-Cited by-同舟云学术

Long-Term Intensive Insulin Therapy for Japanese Patients with Type 2 Diabetes Mellitus

Published:2008 Issue:24 Volume:47 Page:2109-2115
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Umezono Tomoya¹,Toyoda Masao¹,Abe Makiko¹,Kobayashi Keiko¹,Kato Mayuko¹,Miyauchi Masaaki¹,Kobayashi Takako¹,Yamamoto Naoyuki¹,Kimura Moritsugu¹,Yagame Mitsunori¹,Suzuki Daisuke¹

Affiliation:

1. Internal Medicine, Division of Nephrology and Metabolism, Tokai University School of Medicine

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

http://www.jstage.jst.go.jp/article/internalmedicine/47/24/47_24_2109/_pdf

Reference22 articles.

1. The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus

2. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

3. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

4. Induction of Long-term Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients Is Associated With Improvement of β-Cell Function

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Continuous theta burst stimulation provides neuroprotection by accelerating local cerebral blood flow and inhibiting inflammation in a mouse model of acute ischemic stroke;Brain Research;2020-01

2. Short duration of diabetes and disuse of sulfonylurea have any association with insulin cessation of the patients with type 2 diabetes in a clinical setting in Japan (JDDM 30);Endocrine Journal;2013

3. The Impact of Diabetes Mellitus on Coronary Artery Disease: New Therapeutic Approaches;Current Pharmaceutical Design;2009-06-01